Brivaracetam
未知生产厂商
Brivaracetam is an anticonvulsant used for the treatment of partial-onset seizures that functions by binding to synaptic vesicle glycoprotein 2A (SV2A) in the brain.
Brivaracetam is an anticonvulsant used for the treatment of partial-onset seizures that functions by binding to synaptic vesicle glycoprotein 2A (SV2A) in the brain.
The precise mechanism of brivaracetam's anti-epileptogenic activity is unknown.
Used as adjunctive therapy for partial-onset seizures in patients 16 years of age or older.
共 1 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
